Abemaciclib: A New Standard of Care for High-risk EBC Patients

Dear Dr. Renukaprasad A R, Can adding abemaciclib to endocrine therapy (ET) provide additional benefits in patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-), node-positive, early breast cancer (EBC)? For answers to this and other pressing questions, join us for an interactive webinar on 31st March 2023, from 8:00-9:30 PM, where renowned oncologists Dr. Olga Oikonomidou (UK), Dr. Sandeep Goyle (India), Dr. Tejinder Singh (India), and Dr. Shivam Shingla (India) will discuss the clinical efficacy and benefits of abemaciclib in HR+/HER2-, node-positive, high-risk EBC patients. Session highlights: Benefits of abemaciclib beyond treatment completion in the adjuvant setting 4-year updates - Dr. Olga Oikonomidou Updates from ESMO 2022: Monarch 3 overall survival interim analysis - Dr. Tejinder Singh Case by case: Applying MonarchE data into clinical practice - Dr. Olga Oikonomidou Q&A with experts - Moderated by Dr. Sandeep Goyle Save the Date Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Co-management of DED and Ocular Surgery

Dear Dr. Renukaprasad A R, What is your opinion about dry eye disease (DED) and its co-management by optometrists and ophthalmologists during ocular surgeries? DED complications often remain unrecognized and, therefore, untreated. And even if they get treated promptly, ocular surgeries can set de novo DED in motion or worsen a pre-existing one. Hence, optometrists and ophthalmologists must be aware of surgical procedures requiring cross-referrals between them about ocular surface disease (OSD) signs, symptoms, assessments, management, and recommendations during pre-, peri-, and post-surgical phases. View this infographic that highlights different ways to manage DED with ocular surgeries! Highlights: DED and its complications De novo and pre-existing DED LASIK and cataract surgeries for DED Optometrists and ophthalmologists' cross-referrals Read More Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India: Hospitals Violate PMJAY Ayushman Bharat Scheme, and More

Dear Dr. Renukaprasad A R, Top Stories of the Day: India: Hospitals Violate PMJAY Ayushman Bharat Scheme Singapore: Rise in COVID-19 Cases USFDA: Drug Manufacturer Recalls Dabigatran Etexilate Retinopathy Helps to Diagnose Alzheimer's Disease Webinar: Overview of Gallbladder Carcinoma Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Coming up Next Week - Immunotherapy in Cancer & More!

Hi Renukaprasad A R, This week, we bring you exclusive webinars like ClinShots, MasterSeries, Dent-E-ssentials, webinars in association with CIMS, and more. Join experts as they help us discover recent updates and trends in the field of medicine. Be a part of our virtual sessions dedicated to enlightening you with explicit knowledge. STAY TUNED!! Immunotherapy I BPH I Kidney Disease Management Immunotherapy in cancer care has long been a topic of discussion in terms of its clinical outcomes and its effect on disease progression and management. However, is immunotherapy a new hope or just hype in cancer care? New medical management strategies have been gaining popularity due to their effectiveness in managing benign prostatic hyperplasia. However, can these strategies eliminate the need for surgical management?  Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to slow the progression of chronic kidney diseases. There may be untapped new horizons in the management of the same.  Join our exclusive webinar, organized in association with CIMS, on "Immunotherapy, BPH, and Kidney Disease Management" with experts in the field on 27th March 2023, 6:00 PM IST onwards! Save the Date Coming Up Next Case Discussions in HCC Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. In the early stage, treatments such as surgical resection, liver transplants, and local ablation can improve survival. However, if it is detected at an advanced stage, as is often the case, the available therapies are restricted to palliative care and local treatment. Early detection and surveillance of high-risk groups are therefore crucial to increase survival and patient's quality of life.   Join renowned hepatologist Dr. Akash Shukla and the panel of leading experts in an exclusive ClinShots session on "Case Discussions in HCC" on 28th March 2023, 6:00 PM IST onwards. Add to Your Calendar Nutrition for Babies with Cleft Defects Babies born with a cleft lip and/or palate have special nutritional needs. They often have digestive complications and issues like nasal regurgitation. Therefore, it is imperative to know about nutritional requirements for the optimum growth and development of babies with a cleft lip.  Join our exclusive webinar with the reputed cleft surgeon, Dr. Subodh Singh, on "Cleft - Nutrition & Care After Birth" on 30th March 2023, 6:00 PM IST onwards! View Webinar Details More Insightful Webinars This week! Mar 27, 3:00 PM IST onwards Glossopharyngeal Neuralgia: An Overview Mar 28, 3:00 PM IST onwards Vertigo: Understanding Yesterday, Today & Tomorrow Mar 29, 3:00 PM IST onwards MasterSeries: Overview of Gallbladder Carcinoma Mar 29, 6:00 PM IST onwards Restorative Neurosurgery Mar 31, 3:00 PM IST onwards Dent-E-ssentials: Clear Aligners: The Future is Here! Apr 2, 6:00 PM IST onwards Current Trends in Managing IBD: Irritable Bowel Syndrome Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 Change email preference | Unsubscribe